Professor of Medicine, Oncology, and Health Sciences Informatics at JHU SOM; Vice Chair of Medicine for Data Integrity and Analytics; Associate Director, Infectious Diseases Fellowship Training Program; Janeway Firm Faculty of the Osler Residency Program
Infectious Disease
Dr. Stuart C. Ray, MD
|
|
Give Review
Stuart is an expert in the field of Infectious Disease. He studied medicine at Vanderbilt University School of Medicine. He has 2 awards "Elected Member" and "Fellow". Doctor Stuart C. Ray, MD is a published MD as well. He has 97 publications published. The latest was: Recrudescence of treated neurosyphilis in a patient with human immunodeficiency virus. Stuart accepts all Medicare patients.
Publications
- Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.
- Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.
- Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance.
- Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2.
- Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins.
- Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome.
- Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.
- Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.
- Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.
- Clearance of Hepatitis C infection is associated with early appearance of broad neutralizing antibody responses.
- PANGEA-HIV: phylogenetics for generalised epidemics in Africa.
- CD4+ T cell-dependent reduction in hepatitis C virus-specific neutralizing antibody responses following coinfection with human immunodeficiency virus.
- Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infe...
- Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes.
- Accelerating drug development through collaboration: the Hepatitis C Drug Development Advisory Group.
- Antiretroviral therapy, Interferon Sensitivity, and Virologic Set Point in HIV-Hepatitis C Virus Co-infected Patients.
- Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.
- The Role of Viral Introductions in Sustaining Community-Based HIV Epidemics in Rural Uganda: Evidence from Spatial Clustering, Phylogenetics, and Egocentric Transmissi...
- Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver.
- Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents.
- Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure.
- Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.
- Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.
- Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial.
- The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).
- Molecular Epidemiology of HIV Type 1 in Singapore and Identification of Novel CRF01_AE/B Recombinant Forms.
- Hepatitis C virus infection of neuroepithelioma cell lines.
- Analysis of HIV diversity using a high-resolution melting assay.
- Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.
- Genetic linkage of hepatitis B virus in peripheral blood leukocytes provides evidence for contamination.
- HIV-1 evolution following transmission to an HLA-B*5801-positive patient.
- High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.
- Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.
- High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate a...
- Maternal neutralizing antibody and transmission of hepatitis C virus to infants.
- Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire.
- Severe pruritus after completing pegylated interferon for hepatitis C.
- Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.
- Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
- Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
- CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load.
- Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples.
- Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.
- Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
- Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circ...
- Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on hig...
- Humoral immune response in acute hepatitis C virus infection.
- Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.
- Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.
- Cellular immune selection with hepatitis C virus persistence in humans.
- Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.
- A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
- Molecular epidemiology of HIV-1 subtypes in southern China.
- G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
- Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons.
- Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.
- Cross-genotype immunity to hepatitis C virus.
- Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.
- Characterization of novel recombinant HIV-1 genomes using the branching index.
- Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive anti...
- Needlestick transmission of hepatitis C.
- A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
- Eukaryotic start and stop translation sites.
- Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India.
- Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.
- Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with ...
- Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.
- Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
- Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active a...
- A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or fr...
- Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies.
- HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
- Dynamics of SEN virus infection among injection drug users.
- Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression.
- Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy.
- Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees.
- Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs.
- Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env.
- Genetic epidemiology of hepatitis C virus throughout egypt.
- Protection against persistence of hepatitis C.
- Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.
- Determinants of the quantity of hepatitis C virus RNA.
- Presence in India of HIV type 1 similar to North American strains.
- Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression.
- Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users.
- Predominance of defective proviral sequences in an HIV + long-term non-progressor.
- Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
- A 61 year-old female with a prior history of tuberculosis presenting with hemoptysis.
- Determinants of viral clearance and persistence during acute hepatitis C virus infection.
- Evolution of human immunodeficiency virus type 1 in relation to disease progression in children.
- PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease.
- Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdri...
- Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
- Recrudescence of treated neurosyphilis in a patient with human immunodeficiency virus.
- Ecchymoses and eschars at sites of injection.
- Sex and the genetic diversity of HIV-1.
Schools
Vanderbilt University
Johns Hopkins University Hospital
California Institute Of Technology
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Elected Member
- Fellow
Education
-
Johns Hopkins University -
Vanderbilt University School of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1679565840 | |
| NPPES Provider LastName | RAY | |
| NPPES Provider FirstName | STUART | |
| NPPES Provider ZIPCode | 212870020 | |
| NPPES Provider State | MD | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 47.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 25.53 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679565840 |
| Last Name Of The Provider | RAY |
| First Name Of The Provider | STUART |
| View All |
Similar Doctors
|
|
Dr. Anthony O. Edozien, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadia Zahid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Sulkowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen C. Carroll, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Philip A. Mackowiak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luciano Kapelusznik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne M. Rompalo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jakub K. Simon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael E. Kleinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia Sears, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Graeme N. Forrest, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Holmes, MD |